Aging blood stem cells weaken immunity. Latest research shows drugs and reprogramming can restore their function, promising healthier aging. New research reveals that aging blood stem cells can be pha...
Recent research quantifies how systemic inflammation, measured by CRP and immune cells, contributes to mortality risk in older adults, with strong implications for diabetes care. A new large-scale stu...
Researchers combine dichloroacetate and metformin with a 10-fold lower Navitoclax dose, selectively clearing senescent cells while limiting platelet toxicity and advancing clinical senolytic use. A ne...
Senomorphic drugs aim to tame the harmful effects of senescent cells without killing them, offering a more targeted approach to age-related diseases. A new wave of drugs called senomorphics could chan...
A new framework, inflammatory fidelity, shifts the focus from blanket anti-inflammatory measures to the precision of immune responses, offering a deeper path to healthy aging and individualized longev...
Senolytic drugs restore stem cell function in aged mice, raising hopes for treating sarcopenia and frailty in humans. But safety hurdles remain. Cellular senescence is stealing stem cells’ regen...
New research links inflammaging and immunosenescence to Alzheimer’s and Parkinson’s, with immune-modulating therapies showing early promise. Aging of the immune system accelerates brain di...
Recent studies reveal that immune aging, or ‘inflammaging,’ is a modifiable risk factor for neurodegenerative diseases, with new biomarkers and senolytic drugs offering hope for early inte...
A 2024 Nature Aging study shows IGF1R inhibitors PPP and NVP-ADW742 extend healthspan by 8–12% but cause GI bleeding and cardiotoxicity, questioning their therapeutic potential. A 2024 mouse study r...
New research reveals an inverse relationship between cancer and neurodegenerative diseases, offering evolutionary insights for dual therapies targeting healthy aging. Could the same biological pathway...